医药电商背景下华北制药盈利能力分析与改进研究

Analysis and Enhancement Research of Profitability at North China Pharmaceutical under the Background of Pharmaceutical E-Commerce

摘要: 本文基于医药电商快速发展的背景，以华北制药为研究对象，结合其2020~2024年财务报告数据，综合运用财务指标分析与案例研究方法，系统探讨其盈利能力现状、问题及改进路径。研究发现，华北制药在品牌信誉、成本控制与研发投入方面具备一定优势，但在电商转型过程中，面临线上线下业务割裂、数字运营能力不足、盈利模式单一等挑战，导致其总资产收益率与净资产收益率长期低于行业平均水平。为此，本文提出构建全域融合的数字化运营体系、优化电商成本结构、强化数据驱动决策、建设智慧供应链等改进策略，以促进其线上线下协同发展，提升整体盈利能力。研究旨在为传统制药企业在医药电商背景下的数字化转型与盈利能力提升提供理论参考与实践路径。

Abstract: Against the backdrop of the rapid development of pharmaceutical e-commerce, this study takes North China Pharmaceutical (NCPC) as the research object. Utilizing financial report data from 2020 to 2024 and integrating financial indicator analysis with case study methods, it systematically examines the company’s current profitability, identifies existing problems, and explores potential improvement pathways. The research finds that while NCPC possesses certain advantages in brand reputation, cost control, and R&D investment, it faces significant challenges during its e-commerce transition. These include a disconnect between online and offline operations, insufficient digital operational capabilities, and a singular profit model, which collectively contribute to its Return on Assets (ROA) and Return on Equity (ROE) consistently remaining below the industry average. Consequently, this paper proposes several improvement strategies. These include building an integrated group-wide digital operation system, optimizing the e-commerce cost structure, strengthening data-driven decision-making, and establishing an intelligent supply chain. The aim is to foster synergistic development between online and offline channels and enhance overall profitability. This research intends to provide theoretical insights and practical pathways for traditional pharmaceutical enterprises seeking to improve profitability through digital transformation in the era of pharmaceutical e-commerce.